Invention Grant
US07728109B2 Antagonistic anti-hTNFSF13b human antibodies 有权
拮抗性抗hTNFSF13b人抗体

  • Patent Title: Antagonistic anti-hTNFSF13b human antibodies
  • Patent Title (中): 拮抗性抗hTNFSF13b人抗体
  • Application No.: US11952363
    Application Date: 2007-12-07
  • Publication No.: US07728109B2
    Publication Date: 2010-06-01
  • Inventor: Kristine Kay Kikly
  • Applicant: Kristine Kay Kikly
  • Applicant Address: US IN Indianapolis
  • Assignee: Eli Lilly and Company
  • Current Assignee: Eli Lilly and Company
  • Current Assignee Address: US IN Indianapolis
  • Agent Sanjay M. Jivraj; Gregory A. Cox
  • Main IPC: C07K16/24
  • IPC: C07K16/24
Antagonistic anti-hTNFSF13b human antibodies
Abstract:
Human monoclonal antibodies that specifically bind to TNFSF13b polypeptides are disclosed. These antibodies have high affinity for hTNFSF13b (e.g., KD=10−8 M or less), a slow off rate for TNFSF13b dissociation (e.g., Koff=10−3 sec−1 or less) and neutralize TNFSF13b activity in vitro and in vivo. The antibodies of the invention are useful in one embodiment for inhibiting TNFSF13b activity in a human subject suffering from a disorder in which hTNFSF13b activity is detrimental. Nucleic acids encoding the antibodies of the present invention, as well as, vectors and host cells for expressing them are also encompassed by the invention.
Public/Granted literature
Information query
Patent Agency Ranking
0/0